Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Assets Average (2021 - 2025)

Rani Therapeutics Holdings has reported Assets Average over the past 5 years, most recently at $34.4 million for Q4 2025.

  • Quarterly results put Assets Average at $34.4 million for Q4 2025, down 14.24% from a year ago — trailing twelve months through Dec 2025 was $34.4 million (down 14.24% YoY), and the annual figure for FY2025 was $47.6 million, up 0.75%.
  • Assets Average for Q4 2025 was $34.4 million at Rani Therapeutics Holdings, up from $13.5 million in the prior quarter.
  • Over the last five years, Assets Average for RANI hit a ceiling of $130.6 million in Q4 2021 and a floor of $13.5 million in Q3 2025.
  • Median Assets Average over the past 5 years was $70.6 million (2023), compared with a mean of $72.3 million.
  • Biggest five-year swings in Assets Average: dropped 0.81% in 2022 and later crashed 69.02% in 2025.
  • Rani Therapeutics Holdings' Assets Average stood at $130.6 million in 2021, then decreased by 17.21% to $108.1 million in 2022, then tumbled by 40.64% to $64.2 million in 2023, then plummeted by 37.54% to $40.1 million in 2024, then fell by 14.24% to $34.4 million in 2025.
  • The last three reported values for Assets Average were $34.4 million (Q4 2025), $13.5 million (Q3 2025), and $20.5 million (Q2 2025) per Business Quant data.